Pharma stock surged nearly 2 percent on Thursday morning following the announcement of receiving U.S. FDA approval for its new HIV drug. The approval paves the way for the company to market its generic version of a widely used HIV treatment, enhancing its position in the competitive pharmaceutical market.  Price Movement  In Thursday’s trading session, … Continue reading Pharma stock in green after receiving approval from USFDA for new generic HIV tablets